Institution
King Hussein Cancer Center
Nonprofit•Amman, Jordan•
About: King Hussein Cancer Center is a nonprofit organization based out in Amman, Jordan. It is known for research contribution in the topics: Cancer & Breast cancer. The organization has 849 authors who have published 866 publications receiving 12429 citations.
Topics: Cancer, Breast cancer, Transplantation, Population, Health care
Papers published on a yearly basis
Papers
More filters
••
TL;DR: This review provides an objective and comprehensive account of the cellular uptake of NPs and the underlying parameters controlling the nano-cellular interactions, along with the available analytical techniques to follow and track these processes.
Abstract: Nanoscale materials are increasingly found in consumer goods, electronics, and pharmaceuticals. While these particles interact with the body in myriad ways, their beneficial and/or deleterious effects ultimately arise from interactions at the cellular and subcellular level. Nanoparticles (NPs) can modulate cell fate, induce or prevent mutations, initiate cell–cell communication, and modulate cell structure in a manner dictated largely by phenomena at the nano–bio interface. Recent advances in chemical synthesis have yielded new nanoscale materials with precisely defined biochemical features, and emerging analytical techniques have shed light on nuanced and context-dependent nano-bio interactions within cells. In this review, we provide an objective and comprehensive account of our current understanding of the cellular uptake of NPs and the underlying parameters controlling the nano-cellular interactions, along with the available analytical techniques to follow and track these processes.
1,498 citations
••
Harvard University1, Pan American Health Organization2, Livestrong Foundation3, The Global Fund to Fight AIDS, Tuberculosis and Malaria4, American Society of Clinical Oncology5, China Medical Board6, University of California, San Francisco7, Seattle Cancer Care Alliance8, Global Forum for Health Research9, Imperial College London10, Public Health Foundation of India11, Columbia University12, King Hussein Cancer Center13, American Cancer Society14
TL;DR: The public health community's assumption that cancers will remain untreated in poor countries is challenged, and the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment is noted.
662 citations
••
TL;DR: This article analyzes the interaction of nanoparticle surface and ligands with different chemical groups, the types of bonding, the final dispersibility of ligand-coated nanoparticles in complex media, their reactivity, and their performance in biomedicine, photodetectors, photovoltaic devices, light-emitting devices, sensors, memory devices, thermoelectric applications, and catalysis.
Abstract: The design of nanoparticles is critical for their efficient use in many applications ranging from biomedicine to sensing and energy. While shape and size are responsible for the properties of the inorganic nanoparticle core, the choice of ligands is of utmost importance for the colloidal stability and function of the nanoparticles. Moreover, the selection of ligands employed in nanoparticle synthesis can determine their final size and shape. Ligands added after nanoparticle synthesis infer both new properties as well as provide enhanced colloidal stability. In this article, we provide a comprehensive review on the role of the ligands with respect to the nanoparticle morphology, stability, and function. We analyze the interaction of nanoparticle surface and ligands with different chemical groups, the types of bonding, the final dispersibility of ligand-coated nanoparticles in complex media, their reactivity, and their performance in biomedicine, photodetectors, photovoltaic devices, light-emitting devices, sensors, memory devices, thermoelectric applications, and catalysis.
616 citations
••
University of Nottingham1, King Saud Medical City2, International Centre for Diarrhoeal Disease Research, Bangladesh3, Government Medical College, Thiruvananthapuram4, Centers for Disease Control and Prevention5, Ljubljana University Medical Centre6, Kantonsspital St. Gallen7, Institut de veille sanitaire8, Children's Hospital at Westmead9, Mexican Social Security Institute10, Medical University of Vienna11, Capital Medical University12, University of Barcelona13, University of Colorado Denver14, State University of West Paraná15, Sheba Medical Center16, University of Manitoba17, Peking University18, National Institutes of Health19, Hospital General Universitario Gregorio Marañón20, Statens Serum Institut21, Imperial College London22, Boston Children's Hospital23, Peking Union Medical College Hospital24, Dhaka Medical College and Hospital25, Universidade Federal de Ciências da Saúde de Porto Alegre26, Gold Coast Hospital27, Tehran University of Medical Sciences28, University of Oxford29, University of Zagreb30, Pamela Youde Nethersole Eastern Hospital31, Stellenbosch University32, Shiraz University of Medical Sciences33, Tan Tock Seng Hospital34, University of Helsinki35, China Medical University (PRC)36, King Hussein Cancer Center37, University of Toronto38, Alfaisal University39, Erciyes University40, Lithuanian University of Health Sciences41, Military Medical Academy42, University of Bergen43, Haukeland University Hospital44, Johns Hopkins University School of Medicine45, Shahid Beheshti University of Medical Sciences and Health Services46, University of Birmingham47, Rambam Health Care Campus48, Vanderbilt University49, Charité50, University of Bristol51, Yüzüncü Yıl University52, Oswaldo Cruz Foundation53, Rzeszów University54, University Hospital of Basel55, Medical University of Warsaw56, University of Alberta Hospital57, University of Alberta58, University of Hong Kong59, National Center for Immunization and Respiratory Diseases60, VU University Medical Center61
TL;DR: There was an increase in the mortality hazard rate with each day's delay in initiation of treatment up to day 5 as compared with treatment initiated within 2 days of symptom onset, and early treatment versus no treatment was also associated with a reduction in mortality risk.
527 citations
••
TL;DR: Multivariate analysis showed that age, histologic subtype, primary site location, stage, and local control with surgery and/or radiation were significant predictors of survival, however, alveolar subtype and unfavorable primary site lost significance when analysis was restricted to adults.
Abstract: Purpose To compare clinical features and outcomes of adults and children reported to have rhabdomyosarcoma. Patients and methods We analyzed data from 1,071 adults (age > 19 years) and 1,529 children (age Results Adults with rhabdomyosarcoma had significantly worse outcome than children (5-year overall survival rates, 27% +/- 1.4% and 61% +/- 1.4%, respectively; P Conclusion Adults reported to have rhabdomyosarcoma had worse survival than children with similar tumors. Predictors of poor outcome in children were valid in adults except for alveolar histology and unfavorable tumor site.
352 citations
Authors
Showing all 860 results
Name | H-index | Papers | Citations |
---|---|---|---|
Lawrence M. Pfeffer | 55 | 202 | 11010 |
Ahmed Salem | 38 | 271 | 6477 |
Ibrahim Qaddoumi | 34 | 149 | 5041 |
Robert Rejdak | 26 | 277 | 2483 |
Iyad Sultan | 25 | 101 | 4195 |
Osama Alsmadi | 23 | 81 | 1929 |
Suleiman Massarweh | 21 | 49 | 4037 |
Mohammed Odeh | 20 | 112 | 14152 |
Maysa Al-Hussaini | 17 | 115 | 1188 |
Maher A. Sughayer | 17 | 75 | 1062 |
Mario Damiano Toro | 17 | 93 | 883 |
Abdelghani Tbakhi | 16 | 72 | 1028 |
Feras Hawari | 16 | 62 | 1414 |
Asem Mansour | 15 | 64 | 790 |
Hikmat Abdel-Razeq | 14 | 90 | 763 |